Willingsford

Pilot study: Evaluation of ease-of-use of Aprobaxil as first-line treatment for active Hidradenitis Suppurativa lesions

We, Willingsford, are recruiting volunteers with active HS lesions. The aim of the evaluation is to optimise the ease-of-use of Aprobaxil as first-line treatment of active Hidradenitis Suppurativa lesions without sinus tracts.   Purpose The overall purpose of the study is to determine how to optimally use Aprobaxil…

Chair of the WHO Antimicrobial Resistance (AMR) group

Publication shows that MPPT acts as a passive immunotherapy that interacts with the microbiome and calls for a paradigm shift in the treatment of wounds and ulcers (Sams-Dodd et al. 2018). In response to these findings, Executive Board member of the World Health Organization (WHO), and chair of…

End of content

No more pages to load